Health Canada Drug Approval Process: A Barrier to Personalized Care in Multiple Sclerosis.
Resource Type
Academic Journal
Authors
Oh J; Barlo MS Centre, Division of Neurology, Department of Medicine, St. Michael's Hospital, Toronto, Ontario, Canada.; Bhan V; University of British Columbia, Vancouver, British Columbia, Canada.; Traboulsee A; Faculty of Medicine, Division of Neurology, University of British Columbia, Vancouver, British Columbia, Canada.; Morrow SA; University of Calgary, Hotchkiss Brain Institute, Calgary, Alberta, Canada.; Lee L; Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.; Levin M; Office of the Saskatchewan Multiple Sclerosis Clinical Research Chair, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.; Casserly C; London Health Sciences Centre, London, Ontario, Canada.; Freedman MS; University of Ottawa Department of Medicine, and the Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.; Giacomini PS; Montreal Neurological Institute and Hospital, Montreal, Québec, Canada.; Émond F; CHU de Québec (Université Laval) & CIUSSS Capitale-Nationale - IRDPQ, Quebec City, Québec, Canada.; Smyth P; Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Alberta, Canada.; Clift F; Memorial University, St. John's, Newfoundland and Labrador, Canada.; Selchen D; Barlo MS Centre, Division of Neurology, Department of Medicine, St. Michael's Hospital, Toronto, Ontario, Canada.
Source
Publisher: published by Cambridge University Press for the Canadian Neurological Sciences Federation Country of Publication: England NLM ID: 0415227 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 0317-1671 (Print) Linking ISSN: 03171671 NLM ISO Abbreviation: Can J Neurol Sci Subsets: MEDLINE